Compare EXP & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXP | RDNT |
|---|---|---|
| Founded | 1963 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.4B |
| IPO Year | 1994 | 1986 |
| Metric | EXP | RDNT |
|---|---|---|
| Price | $224.51 | $79.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $252.22 | $83.60 |
| AVG Volume (30 Days) | 397.4K | ★ 918.0K |
| Earning Date | 10-30-2025 | 11-09-2025 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 13.52 | N/A |
| Revenue | ★ $2,301,796,000.00 | $1,969,599,000.00 |
| Revenue This Year | $2.85 | $10.02 |
| Revenue Next Year | $4.52 | $8.54 |
| P/E Ratio | $16.66 | ★ N/A |
| Revenue Growth | 1.50 | ★ 11.09 |
| 52 Week Low | $191.91 | $45.00 |
| 52 Week High | $304.57 | $85.84 |
| Indicator | EXP | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 50.41 |
| Support Level | $219.30 | $78.88 |
| Resistance Level | $226.34 | $85.84 |
| Average True Range (ATR) | 5.24 | 3.10 |
| MACD | 3.02 | -0.13 |
| Stochastic Oscillator | 90.76 | 54.35 |
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.